Technology developed by a University of Cambridge professor to improve the lives of people living with type 1 diabetes and their families has received approval for use in the US.
This means that even more people living with the disease will be able to use this life-changing app. For the first time, the FDA authorised the use of the
An artificial pancreas developed by researchers at the University of Cambridge has been granted approval by the U.S. Food and Drug Administration (FDA) for use by individuals with type 1 diabetes aged 2 and older, including during pregnancy.